Latest news, press releases, and SEC filings for Xeris Biopharma Holdings Inc (XERS) https://caymanjournal.com/stock/XERS en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 22:45:08 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This is the 2025 Annual Report (Form 10-K) for Xeris Biopharma. Think of it as the company's official, comprehensive report card for the entire year. It’s filed with the SEC and is packed with detailed information about the business, its financial results, the risks it fac https://caymanjournal.com/stock/XERS/sec-filing/0001867096-26-000023 https://caymanjournal.com/stock/XERS/sec-filing/0001867096-26-000023 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is — Your Invitation to a Company Vote This is a **proxy statement** (Form DEF 14A) for Xeris Biopharma. Think of it as an official invitation and handbook for the company's annual meeting. Its job is to give shareholders the information they need to vote on important compan https://caymanjournal.com/stock/XERS/sec-filing/0001867096-26-000021 https://caymanjournal.com/stock/XERS/sec-filing/0001867096-26-000021 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing